What is the equianalgesic dose of morphine intravenous (IV) for hydromorphone 1 milligram intravenous (IV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The equianalgesic dose of morphine IV for hydromorphone 1mg IV is approximately 6.67 mg, based on the ratio of equianalgesic doses provided in the clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit 1. This conversion is crucial when switching between opioid medications to maintain adequate pain control while avoiding under or overdosing.

  • Hydromorphone (Dilaudid) is more potent than morphine on a milligram-to-milligram basis, which explains the ratio.
  • The table provided in the guidelines lists the equianalgesic dose of morphine as 10mg and hydromorphone as 1.5mg, resulting in a ratio of approximately 6.67:1. When making this conversion in clinical practice, it's essential to consider individual patient factors such as:
  • Age
  • Renal function
  • Prior opioid exposure
  • Pain severity Additionally, due to incomplete cross-tolerance between opioids, when switching from one opioid to another, a dose reduction of 25-50% from the calculated equianalgesic dose is often recommended to reduce the risk of adverse effects while maintaining pain control, as suggested by the guidelines 1. Close monitoring for efficacy and side effects is essential after any opioid conversion.

From the Research

Equianalgesic Dose of Morphine IV for Hydromorphone 1mg IV

  • The equianalgesic dose of morphine IV for hydromorphone 1mg IV is not explicitly stated in the provided studies 2, 3, 4, 5, 6.
  • However, study 5 discusses equianalgesic dosing of opioids, including hydromorphone, but does not provide a specific conversion ratio for hydromorphone 1mg IV to morphine IV.
  • Study 4 mentions that the issue of equi-analgesic ratios between morphine and hydromorphone was not resolved in the context of both acute and chronic pain.
  • Study 3 compares the efficacy and safety of hydromorphone and morphine in older adults with acute, severe pain, but does not provide a direct conversion ratio.
  • Study 6 also explores the evidence for the efficacy of hydromorphone in the management of pain, but does not provide a specific equianalgesic dose ratio for hydromorphone to morphine.
  • Study 2 provides a lecture and infographic on morphine equianalgesic doses, but does not specifically address the conversion ratio for hydromorphone 1mg IV to morphine IV 2.

Limitations

  • The provided studies do not offer a clear and direct conversion ratio for hydromorphone 1mg IV to morphine IV.
  • The studies have varying levels of quality and methodology, making it challenging to determine a precise equianalgesic dose ratio 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Morphine Equianalgesic Dose Chart in the Emergency Department.

Journal of education & teaching in emergency medicine, 2022

Research

Hydromorphone for acute and chronic pain.

The Cochrane database of systematic reviews, 2002

Research

Equianalgesic dosing of opioids.

Journal of pain & palliative care pharmacotherapy, 2006

Research

A systematic review of hydromorphone in acute and chronic pain.

Journal of pain and symptom management, 2003

Related Questions

If hydromorphone is not available, should morphine or fentanyl be used as an alternative for pain management?
What is the difference between morphine (opioid analgesic) injection and hydromorphone (opioid analgesic)?
Can I give Dilaudid (hydromorphone) to a patient with an allergy to morphine?
What is the initial dose of Butrans (buprenorphine) for a patient being converted from Hydromorphone (dilaudid) due to gastrointestinal side effects, to maintain adequate analgesia?
What are the alternative pain management options for a patient with stage 4 pancreatic cancer already taking hydromorphone (opioid)
What causes Streptococcus mitis (S. mitis) bacteremia?
What is the HbA1c (Hemoglobin A1c) cutoff for discontinuing treatment in patients over 75 years old?
Can colon cancer cause Streptococcus mitis (S. mitis) bacteremia?
What is the most likely cause of a 56-year-old gentleman's symptoms, including tingling on the left side of his face, dilation of the left pupil, abnormal extraocular movement of the left eye, drooping of the left eyelid, and light sensitivity, with a computed tomography (CT) scan showing a posterior communicating artery aneurysm?
What is the most likely cause of a 56-year-old gentleman's symptoms, including tingling on the left side of his face, dilation of the left pupil, abnormal extraocular movement of the left eye, drooping of the left eyelid, and light sensitivity, with a computed tomography (CT) scan showing a posterior communicating artery aneurysm?
At what age can HbA1c (hemoglobin A1c) testing be stopped?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.